TABLE 4.

Composition of nine DTaP vaccines evaluated in efficacy trials^a

Vaccineb	Amt of B. pertussis antigens (μg/dose)				Amt. of aluminum (mg/dose)	Preservative	Flocculationc
	PT	FHA	PRN	FIM			Diphtheria toxoid	Tetanus toxoid
Certivad	40				0.50	Thimerosal	25	7
Tripediad	23.4	23.4			0.17	Thimerosal	6.7	5
PM-2e	25	25			0.30	Thimerosal	15	5
SKB-2e	25	25			0.50	Phenoxyethanol	25	10
Acelluvax	5	2.5	2.5		0.35	Thimerosal	25	10
Infanrixd	25	25	8		0.50	Phenoxyethanol	25	10
ACEL-IMMUNEd	3.5	35	2	0.8f	0.23	Thimerosal	9	5
DAPTACELd	10	5	3	5g	0.33	Phenoxyethanol	15	5
Daptacel-like (enhanced)	20	20	3	5g	0.33	Phenoxyethanol	15	5

^aData from references 149 and 216.

^bTrade names.

^cLimit of flocculation per dose.

^dLicensed in the United States.

^eNo product name.

^fFIM2.

^gFIM2/3.